{"id":443376,"date":"2025-10-06T17:49:10","date_gmt":"2025-10-06T17:49:10","guid":{"rendered":"https:\/\/www.europesays.com\/fr\/443376\/"},"modified":"2025-10-06T17:49:10","modified_gmt":"2025-10-06T17:49:10","slug":"cellura-la-start-up-marseillaise-qui-veut-revolutionner-la-culture-cellulaire","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/fr\/443376\/","title":{"rendered":"Cellura, la start-up marseillaise qui veut r\u00e9volutionner la culture cellulaire"},"content":{"rendered":"<p>Produire \u00e0 grande \u00e9chelle certaines cellules vivantes reste aujourd\u2019hui l\u2019un des <a href=\"https:\/\/www.laprovence.com\/article\/region\/146932164573414\/a-fos-la-start-up-marseillaise-gravithy-leve-60-millions-deuros-pour-produire-du-fer-vert\" target=\"_blank\" rel=\"noopener\">grands d\u00e9fis <\/a>de la biotechnologie. Qu\u2019il s\u2019agisse de <a href=\"https:\/\/www.laprovence.com\/article\/femina-provence\/51718745897764\/en-finlande-les-agriculteurs-du-futur-creent-une-proteine-alimentaire-avec-de-lair\" target=\"_blank\" rel=\"noopener\">cellules<\/a> souches utilis\u00e9es en th\u00e9rapie, de cellules immunitaires pour la m\u00e9decine r\u00e9g\u00e9n\u00e9rative ou encore de cellules destin\u00e9es \u00e0 la viande cultiv\u00e9e, toutes sont extr\u00eamement sensibles aux forces m\u00e9caniques des syst\u00e8mes traditionnels. R\u00e9sultat\u00a0: une production limit\u00e9e, des co\u00fbts tr\u00e8s \u00e9lev\u00e9s et des applications frein\u00e9es.<\/p>\n<p>C\u2019est ce verrou technologique que la start-up marseillaise Cellura, cr\u00e9\u00e9e en\u00a02022 sous le nom de SoftCell Therapeutics, entend lever. Elle vient d\u2019annoncer une <a href=\"https:\/\/www.laprovence.com\/article\/economie\/1100860702248615\/start-up-francaises-le-nombre-de-levees-de-fonds-a-diminue-de-60-au-premier-semestre-2025\" target=\"_blank\" rel=\"noopener\">lev\u00e9e de fonds<\/a> pr\u00e9-seed de 760\u00a0000\u00a0\u20ac, men\u00e9e par le fonds d\u2019investissement Seed for Good avec la participation du family office de Thierry Letartre, fondateur des laboratoires Anios, et du r\u00e9seau Angels&rsquo;Bay Invest.<\/p>\n<p>Un bior\u00e9acteur \u00ab\u00a0g\u00e9o-inspir\u00e9\u00a0\u00bb<\/p>\n<p>Au c\u0153ur de l\u2019innovation de Cellura se trouve SoftXS, un bior\u00e9acteur radicalement diff\u00e9rent des mod\u00e8les conventionnels. Sa cuve cylindrique et inclin\u00e9e, mise en rotation lente, imite un mouvement naturel proche de celui de la Terre. Cette approche permet de m\u00e9langer le milieu de culture en douceur, sans pales ni h\u00e9lices, et donc sans g\u00e9n\u00e9rer de &#8230;<\/p>\n","protected":false},"excerpt":{"rendered":"Produire \u00e0 grande \u00e9chelle certaines cellules vivantes reste aujourd\u2019hui l\u2019un des grands d\u00e9fis de la biotechnologie. Qu\u2019il s\u2019agisse&hellip;\n","protected":false},"author":2,"featured_media":443377,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2814],"tags":[17,1111,11,56966,251,1777,674,1011,27,11989,884,12,882,3583,16,25,56967,675,9870],"class_list":{"0":"post-443376","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-marseille","8":"tag-17","9":"tag-actu","10":"tag-actualites","11":"tag-cellura","12":"tag-culture","13":"tag-eu","14":"tag-europe","15":"tag-fr","16":"tag-france","17":"tag-marseillaise","18":"tag-marseille","19":"tag-news","20":"tag-provence-alpes-cote-dazur","21":"tag-qui","22":"tag-region","23":"tag-republique-francaise","24":"tag-revolutionner","25":"tag-start-up","26":"tag-veut"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@fr\/115328487515783643","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/443376","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/comments?post=443376"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/443376\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media\/443377"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media?parent=443376"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/categories?post=443376"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/tags?post=443376"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}